A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension
Clinical trial NCT07152444 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07152444
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-05-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.